0000899243-21-025758.txt : 20210624 0000899243-21-025758.hdr.sgml : 20210624 20210624173243 ACCESSION NUMBER: 0000899243-21-025758 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210624 FILED AS OF DATE: 20210624 DATE AS OF CHANGE: 20210624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sulzberger Gabrielle CENTRAL INDEX KEY: 0001262388 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39311 FILM NUMBER: 211043888 MAIL ADDRESS: STREET 1: 450 LEXINGTON AVENUE, FLOOR 13 CITY: NEW YORK STATE: NY ZIP: 10017 FORMER NAME: FORMER CONFORMED NAME: Greene-Sulzberger Gabrielle DATE OF NAME CHANGE: 20141030 FORMER NAME: FORMER CONFORMED NAME: GREENE GABRIELLE E DATE OF NAME CHANGE: 20030904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001805387 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 DARTMOUTH STREET STREET 2: SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 844-304-2048 MAIL ADDRESS: STREET 1: 131 DARTMOUTH STREET STREET 2: SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II DATE OF NAME CHANGE: 20200303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-24 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001262388 Sulzberger Gabrielle C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 222 JACOBS STREET, SUITE 200 CAMBRIDGE MA 02141 1 0 0 0 Common Stock 2021-06-24 4 M 0 14270 A 49624 D Restricted Stock Units 2021-06-24 4 M 0 14270 0.00 D Common Stock 14270 14270 D The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 14,270 RSUs vested on June 24, 2021, the second anniversary of the vesting commencement date of June 24, 2019 (the "Vesting Commencement Date"), with the remainder vesting on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service relationship with the Issuer through each such date. /s/ Mark Bodenrader, as Attorney-in-Fact 2021-06-24